Azaserine inhibits the rate limiting step of the metabolic hexosamine pathway and irreversibly inhibits γ-glutamyltransferase by acting directly at the substrate-binding pocket.
Azaserine impedes the rate-limiting step of the metabolic hexosamine pathway and irreversibly blocks γ-glutamyltransferase by directly interacting with the substrate-binding site.